Navigation Links
ResearchDx Launches Contract Diagnostics Organization (CDO)
Date:2/22/2011

IRVINE, Calif., Feb. 22, 2011 /PRNewswire/ -- ResearchDx announced today the official launch of the first-ever Contract Diagnostics Organization or CDO.

Recent FDA initiatives, such as the Critical Path Initiative and the Drug-Diagnostic Co-Development Concept Paper, have spurred biopharmaceutical companies' interest in biomarker research for the purpose of developing companion diagnostics. The traditional Contract Research Organization (CRO), which has focused on clinical trials for pharmaceutical products, cannot meet the need for both an in-depth knowledge of the diagnostics industry and the ability to run diagnostic tests in a clinical laboratory. Conversely, Diagnostics companies lack the ability to perform clinical testing and have an incentive to steer diagnostic development toward their existing products' technology platforms. However, ResearchDx, as a CDO, provides all of these services in an integrated, technology-independent manner that stays focused on their customers' business objectives.

"At ResearchDx, we take contract R&D for diagnostics to the next generation," states co-founder Philip Cotter.  "Our partners trust ResearchDx to provide everything they need to develop a diagnostic product, and that we make their business objectives our priority."

Dr. Philip Cotter and Dr. Mat Moore, the founders of ResearchDx, have a passion for the advancement of personalized medicine. With their team's extensive experience in managing clinical laboratories, designing and managing clinical research, and navigating the complex regulatory environment specific to diagnostics, they saw the opportunity to fill an unmet need for partnership with the biopharmaceutical and diagnostics industries.  In founding the first-ever CDO, they have achieved their vision to help biopharmaceutical companies overcome the barriers to developing diagnostic products.

About ResearchDx

ResearchDx is a Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. The company provides integrated, flexible services for the diagnostic development process – from initial assay concepts and discovery through clinical research to regulatory approval.   ResearchDx's service areas include clinical research, clinical laboratory services, diagnostic manufacturing, and consulting.

CONTACT:  Philip Cotter, +1-510-332-0477, for ResearchDx


'/>"/>
SOURCE ResearchDx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PreXion Launches New Faster, Lower Radiation PreXion3D Elite Cone Beam Imaging System
2. Zimmer Launches PathFinder NXT™ Minimally Invasive Pedicle Screw System
3. Success Factors and Failure Points in Biopharmaceutical Product Launches
4. Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apples App Store(SM)
5. HIMSS11: Ingenious Med Launches Billing and Data Capture App for iPhone, iPod touch and iPad
6. Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India
7. Brainlab Launches Refreshed Website
8. Cayenne Medical, Inc. Launches AperFix® II
9. ForteBio Launches New Octet® RED96 System and Dip and Read™ Protein L Biosensor
10. Mylan Launches First Generic Version of Vfend® Tablets
11. PARI Respiratory Launches New Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):